[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.249.135. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
January 1982

The Effect of Echothiophate on the Biphasic Response of Rabbit Ocular Pressure to Dipivefrin

Author Affiliations

From the Ophthalmology Section, Bronx Veterans Hospital (Dr Mindel); and the Departments of Ophthalmology (Drs Mindel and Orellana and Messrs Koenigsberg and Kharlamb) and Pharmacology (Drs Mindel and Goldfarb), The Mount Sinai School of Medicine, New York.

Arch Ophthalmol. 1982;100(1):147-151. doi:10.1001/archopht.1982.01030030149017
Abstract

• A time-course study was performed on the intraocular pressure response of pigmented rabbit eyes. Dipivefrin administration produced an inital hypertensive phase lasting less than two hours followed by a prolonged hypotensive phase. Echothiophate iodide therapy produced a more pronounced and prolonged hypertensive response; there was no hypotensive phase. Administration of echothiophate plus dipivefrin resulted in a hypertensive phase similar to that from echothiophate alone; as previously reported, this combination was not followed by a hypotensive phase. The α-blocker phentolamine mesylate prevented the echothiophate-induced hypertension. When dipivefrin was administered with echothiophate plus phentolamine, there was an immediate hypotensive effect. It was concluded that the hypertensive effect of echothiophate in pigmented rabbit eyes may mask the hypotensive action of dipivefrin. This, rather than an echothiophate-induced inhibition of esterases, may explain why combination therapy with these drugs seemed ineffective.

References
1.
Norton AL, Viernstein LJ:  The effect of adrenergic agents on ocular dynamics as a function of administration site . Exp Eye Res 1972; 14:154-163.Article
2.
Langham ME, Krieglstein GK:  The biphasic intraocular pressure response of rabbits to epinephrine . Invest Ophthalmol Vis Sci 1976;15:119-127.
3.
Potter DE, Rowland JM:  Adrenergic drugs and intraocular pressure: Effects of selective β-adrenergic agonists . Exp Eye Res 1978;27:615-625.Article
4.
Lee P-F:  The influence of epinephrine and phenylephrine on intraocular pressure . Arch Ophthalmol 1958;60:863-867.Article
5.
Kronfeld PC:  Early effects of single and repeated doses of l-epinephrine in man . Am J Ophthalmol 1971;72:1058-1072.
6.
Wilke K:  Early effects of epinephrine and pilocarpine on the intraocular pressure and the episcleral venous pressure in the normal human eye . Acta Ophthalmol 1974;52:231-241.Article
7.
Anderson JA, Davis WL, Wei C:  Site of ocular hydrolysis of a prodrug, dipivefrin, and a comparison of its ocular metabolism with that of the parent compound, epinephrine . Invest Ophthalmol Vis Sci 1980;19:817-823.
8.
Abramovsky I, Mindel JS:  Dipivefrin and echothiophate: Contraindications to combined use . Arch Ophthalmol 1979;97:1937-1940.Article
9.
Langham ME, Palewicz K:  The pupillary, the intraocular pressure, and the vasomotor responses to noradrenaline in rabbits . J Physiol 1977;267:339-355.
10.
Ross RA, Drance SM:  Effects of topically applied isoproterenol on aqueous dynamics in man . Arch Ophthalmol 1970;83:39-46.Article
11.
Rowland JM, Potter DE:  Adrenergic drugs and intraocular pressure: The hypertensive effect of epinephrine . Ophthalmic Res 1980; 12:221-229.Article
12.
Scholz RO:  Studies on the ocular reactions of rabbits to diisopropyl fluorophosphate . J Pharmacol Exp Ther 1946;88:23-26.
13.
Von Sallmann L, Dillon B:  The effect of diisopropyl fluorophosphate on the capillaries of the anterior segment of the eye in rabbits . Am J Ophthalmol 1947;30:1244-1262.
14.
Stocker FW:  Experimental studies on the blood-aqueous barrier . Arch Ophthalmol 1947; 37:583-590.Article
15.
Neufeld AH, Page ED:  In vitro determination of the ability of drugs to bind to adrenergic receptors . Invest Ophthalmol Vis Sci 1977; 16:1118-1124.
16.
Bethel RA, Eakins KE:  The mechanism of the antagonism of experimentally induced ocular hypertension by polyphloretin phosphate . Exp Eye Res 1971;13:83-91.Article
17.
Podos SM, Becker B, Kass MA:  Prostaglandin synthesis, inhibition and intraocular pressure . Invest Ophthalmol Vis Sci 1973;12:426-433.
×